vimarsana.com
Home
Live Updates
Alkermes plc: Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors : vimarsana.com
Alkermes plc: Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors
- Appoints Nancy J. Wysenski as New Lead Independent Director - - David W. Anstice AO and Wendy L. Dixon, Ph.D. to Retire From Board - - Files Preliminary Proxy Statement and Highlights
Related Keywords
Harvard University
,
Massachusetts
,
United States
,
Boston
,
Athlone
,
Westmeath
,
Ireland
,
Waltham
,
Ohio
,
Cambridge
,
Cambridgeshire
,
United Kingdom
,
Dublin
,
Alex Denner
,
Katie Joyce
,
Emily Peterson Alva
,
Davida Daglio
,
Nancyj Wysenski
,
Catot Laurencin
,
Brianp Mckeon
,
Christopher Wright
,
Wendyl Dixon
,
Vrije Universiteit
,
Sandy Coombs
,
Christopheri Wright
,
Ironwood Pharmaceuticals Inc
,
Global Medicines Development
,
Corporate Governance Committee Of The Board
,
Nasdaq
,
Vertex Pharmaceuticals Incorporated
,
Axcella Health Inc
,
Professor Of Neurology At Harvard Medical School
,
Cyclerion Therapeutics Inc
,
Alkermes
,
Corporate Governance Committee
,
Wendy
,
Harvard Medical School
,
Aavantibio Inc
,
Exchange Commission
,
Biochemical Sciences
,
New Lead Independent Director
,
Retire From Board
,
Preliminary Proxy Statement
,
Highlights Shareholder Engagement Efforts
,
Annual General Meeting
,
Annual Meeting
,
Investor Relations
,
New Independent Director
,
With Significant Neuroscience Expertise
,
Chief Medical Officer
,
Cyclerion Therapeutics
,
Ironwood Pharmaceuticals
,
Associate Professor
,
Harvard Medical
,
Alkerme Board
,
Richard Pops
,
Chief Executive Officer
,
Longer Serving Directors
,
Board Refreshment
,
Lead Independent Director
,
Peterson Alva
,
Sarissa Capital Management
,
Chief Investment Officer
,
Sarissa Capital
,
Senior Vice President
,
Chief Development Officer
,
Axcella Health
,
Scientific Advisor
,
Magna Cum Laude
,
Clinical Investigation
,
Private Securities Litigation Reform Act
,
Annual Report
,
Additional Information
,
Information Regarding Participants
,
Current Reports
,
Initial Statements
,
Beneficial Ownership
,
Vertex Pharmaceuticals
,
Nnounces
,
Ontinued
,
Board
,
Efreshment
,
Ncluding
,
Appointment
,
Christopher
,
Right
,
Directors
,
vimarsana.com © 2020. All Rights Reserved.